{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T14:27:52Z","timestamp":1785421672957,"version":"3.56.0"},"reference-count":78,"publisher":"American Association for Cancer Research (AACR)","issue":"5","license":[{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"vor","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 HL160522"],"award-info":[{"award-number":["T32 HL160522"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30CA016056"],"award-info":[{"award-number":["P30CA016056"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1TR005296"],"award-info":[{"award-number":["UM1TR005296"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32CA085183"],"award-info":[{"award-number":["T32CA085183"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA285707"],"award-info":[{"award-number":["R01CA285707"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Pancreatic ductal adenocarcinoma (PDAC) diagnoses are often accompanied by a number of physical and psychologic symptoms, including anxiety and depression. As a result, many patients are prescribed anxiolytics such as benzodiazepines (BZD) that have unintended effects on the tumor. Previous work from our lab has highlighted that structural differences between BZD compounds may be responsible for different clinical outcomes influenced by their effects on cancer-associated fibroblasts (CAF) within the PDAC tumor microenvironment (TME). In this study, we demonstrate that the commonly prescribed N-substituted triazolobenzodiazepine alprazolam (ALP) abrogates the production of proinflammatory cytokines, including CCL2, CXCL12, interleukin 6 (IL6), and IL8, in human CAFs. This phenotype is unique only to azole-containing BZDs, including midazolam. The ability of ALP to regulate proinflammatory cytokine production is maintained in vivo as ALP-treated mice bearing pancreatic tumors exhibited reductions in IL6 within the tumor interstitial fluid. Mechanistically, an unbiased phosphoproteomic approach revealed that ALP abrogates Toll-like receptor 4\u2013mediated cytokine production in CAFs. These findings cumulatively support that ALP dampens CAF-mediated inflammatory signaling within the PDAC TME.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>The data in the present study focus on the characterization of the effects of ALP on CAF output and provide a compelling basis to suggest that ALP may have a broad impact on remodeling the pancreatic cancer immune landscape and therapeutic response.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-25-0472","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T19:41:01Z","timestamp":1776454861000},"page":"1048-1060","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Alprazolam Reduces Inflammatory Cytokine Production in Pancreatic Cancer\u2013Associated Fibroblasts"],"prefix":"10.1158","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3619-7151","authenticated-orcid":false,"given":"Hunter D.","family":"Reavis","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0499dwk57","id-type":"ROR","asserted-by":"publisher"}],"name":"Roswell Park Comprehensive Cancer Center 1 Department of Pharmacology and Therapeutics, , Buffalo, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4092-6567","authenticated-orcid":false,"given":"Aditi H.","family":"Chaubey","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0499dwk57","id-type":"ROR","asserted-by":"publisher"}],"name":"Roswell Park Comprehensive Cancer Center 1 Department of Pharmacology and Therapeutics, , Buffalo, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1552-6705","authenticated-orcid":false,"given":"Amanda L.","family":"Smythers","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02jzgtq86","id-type":"ROR","asserted-by":"publisher"}],"name":"Dana-Farber Cancer Institute 2 Department of Cancer Biology, , Boston, Massachusetts."},{"name":"3Department of Cell Biology, Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3999-8707","authenticated-orcid":false,"given":"Arwen A.","family":"Tisdale","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0499dwk57","id-type":"ROR","asserted-by":"publisher"}],"name":"Roswell Park Comprehensive Cancer Center 1 Department of Pharmacology and Therapeutics, , Buffalo, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2335-7571","authenticated-orcid":false,"given":"Amanda","family":"Tracz","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0499dwk57","id-type":"ROR","asserted-by":"publisher"}],"name":"Roswell Park Comprehensive Cancer Center 4 Comparative Oncology Shared Resource, , Buffalo, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4573-8626","authenticated-orcid":false,"given":"Alphonse N.","family":"Dimeck","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0499dwk57","id-type":"ROR","asserted-by":"publisher"}],"name":"Roswell Park Comprehensive Cancer Center 5 Department of Cell Stress Biology, , Buffalo, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6280-0324","authenticated-orcid":false,"given":"Kathryn E.","family":"Maraszek","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0499dwk57","id-type":"ROR","asserted-by":"publisher"}],"name":"Roswell Park Comprehensive Cancer Center 1 Department of Pharmacology and Therapeutics, , Buffalo, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0966-6488","authenticated-orcid":false,"given":"Eduardo","family":"Cortes Gomez","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0499dwk57","id-type":"ROR","asserted-by":"publisher"}],"name":"Roswell Park Comprehensive Cancer Center 6 Department of Biostatistics and Bioinformatics, , Buffalo, New York."},{"name":"7Department of Biostatistics, State University of New York at Buffalo, Buffalo, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4291-413X","authenticated-orcid":false,"given":"Joao A.","family":"Paulo","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02jzgtq86","id-type":"ROR","asserted-by":"publisher"}],"name":"Dana-Farber Cancer Institute 2 Department of Cancer Biology, , Boston, Massachusetts."},{"name":"3Department of Cell Biology, Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7167-908X","authenticated-orcid":false,"given":"Subhamoy","family":"Dasgupta","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0499dwk57","id-type":"ROR","asserted-by":"publisher"}],"name":"Roswell Park Comprehensive Cancer Center 5 Department of Cell Stress Biology, , Buffalo, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7626-0034","authenticated-orcid":false,"given":"Steven P.","family":"Gygi","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02jzgtq86","id-type":"ROR","asserted-by":"publisher"}],"name":"Dana-Farber Cancer Institute 2 Department of Cancer Biology, , Boston, Massachusetts."},{"name":"3Department of Cell Biology, Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8189-5568","authenticated-orcid":false,"given":"Michael E.","family":"Feigin","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0499dwk57","id-type":"ROR","asserted-by":"publisher"}],"name":"Roswell Park Comprehensive Cancer Center 1 Department of Pharmacology and Therapeutics, , Buffalo, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2026,5,6]]},"reference":[{"key":"2026050606013050600_bib1","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"key":"2026050606013050600_bib2","volume-title":"SEER*Explorer: an interactive website for SEER cancer statistics [Internet]","author":"National Cancer Institute","year":"2025"},{"key":"2026050606013050600_bib3","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41575-019-0109-y","article-title":"Molecular subtypes of pancreatic cancer","volume":"16","author":"Collisson","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2026050606013050600_bib4","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.3390\/ijms18071338","article-title":"Pancreatic ductal adenocarcinoma: current and evolving therapies","volume":"18","author":"Adamska","year":"2017","journal-title":"Int J Mol Sci"},{"key":"2026050606013050600_bib5","doi-asserted-by":"crossref","first-page":"173","DOI":"10.4251\/wjgo.v12.i2.173","article-title":"Pancreatic ductal adenocarcinoma: treatment hurdles, tumor microenvironment and immunotherapy","volume":"12","author":"Sarantis","year":"2020","journal-title":"World J Gastrointest Oncol"},{"key":"2026050606013050600_bib6","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1176\/ajp.143.8.982","article-title":"Comparative psychological disturbance in patients with pancreatic and gastric cancer","volume":"143","author":"Holland","year":"1986","journal-title":"Am J Psychiatry"},{"key":"2026050606013050600_bib7","doi-asserted-by":"crossref","first-page":"650707","DOI":"10.1100\/2012\/650707","article-title":"Screening for depression, sleep-related disturbances, and anxiety in patients with adenocarcinoma of the pancreas: a preliminary study","volume":"2012","author":"Boyd","year":"2012","journal-title":"ScientificWorldJournal"},{"key":"2026050606013050600_bib8","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/pon.1697","article-title":"Psychological distress in patients with pancreatic cancer\u2013an understudied group: psychological distress in patients","volume":"19","author":"Clark","year":"2010","journal-title":"Psychooncology"},{"key":"2026050606013050600_bib9","doi-asserted-by":"crossref","first-page":"842","DOI":"10.3390\/healthcare12080842","article-title":"Palliative care and mental health among pancreatic cancer patients in the United States: an examination of service utilization and health outcomes","volume":"12","author":"Subramaniam","year":"2024","journal-title":"Healthcare (Basel)"},{"key":"2026050606013050600_bib10","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1182\/blood-2002-07-2044","article-title":"Selective serotonin reuptake inhibitors directly signal for apoptosis in biopsy-like Burkitt lymphoma cells","volume":"101","author":"Serafeim","year":"2003","journal-title":"Blood"},{"key":"2026050606013050600_bib11","doi-asserted-by":"crossref","first-page":"7562","DOI":"10.1158\/0008-5472.CAN-03-4046","article-title":"Fluoxetine inhibits multidrug resistance extrusion pumps and enhances responses to chemotherapy in syngeneic and in human xenograft mouse tumor models","volume":"64","author":"Peer","year":"2004","journal-title":"Cancer Res"},{"key":"2026050606013050600_bib12","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1158\/2159-8290.CD-13-0183","article-title":"A drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumors","volume":"3","author":"Jahchan","year":"2013","journal-title":"Cancer Discov"},{"key":"2026050606013050600_bib13","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.1158\/1078-0432.CCR-15-2535","article-title":"Inhibition of FoxM1-mediated DNA repair by imipramine blue suppresses breast cancer growth and metastasis","volume":"22","author":"Rajamanickam","year":"2016","journal-title":"Clin Cancer Res"},{"key":"2026050606013050600_bib14","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1016\/j.cell.2025.04.032","article-title":"Serotonin transporter inhibits antitumor immunity through regulating the intratumoral serotonin axis","volume":"188","author":"Li","year":"2025","journal-title":"Cell"},{"key":"2026050606013050600_bib15","doi-asserted-by":"crossref","first-page":"113985","DOI":"10.1016\/j.biopha.2022.113985","article-title":"The application of antidepressant drugs in cancer treatment","volume":"157","author":"Zheng","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"2026050606013050600_bib16","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.tips.2020.10.001","article-title":"Unintended effects of GPCR-targeted drugs on the cancer phenotype","volume":"41","author":"Cornwell","year":"2020","journal-title":"Trends Pharmacol Sci"},{"key":"2026050606013050600_bib17","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1158\/1078-0432.CCR-23-0547","article-title":"Lorazepam stimulates IL6 production and is associated with poor survival outcomes in pancreatic cancer","volume":"29","author":"Cornwell","year":"2023","journal-title":"Clin Cancer Res"},{"key":"2026050606013050600_bib18","doi-asserted-by":"crossref","first-page":"e33929","DOI":"10.1016\/j.heliyon.2024.e33929","article-title":"Site specific binding pattern of benzodiazepines with GABAA receptor and related impact on their activities in the human body: an in silico method based study","volume":"10","author":"Roy","year":"2024","journal-title":"Heliyon"},{"key":"2026050606013050600_bib19","doi-asserted-by":"crossref","first-page":"6359","DOI":"10.1158\/0008-5472.CAN-13-1558-T","article-title":"Interleukin-6 is required for pancreatic cancer progression by promoting MAPK signaling activation and oxidative stress resistance","volume":"73","author":"Zhang","year":"2013","journal-title":"Cancer Res"},{"key":"2026050606013050600_bib20","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ccr.2011.03.009","article-title":"Stat3\/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer","volume":"19","author":"Lesina","year":"2011","journal-title":"Cancer Cell"},{"key":"2026050606013050600_bib21","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ccr.2011.03.002","article-title":"Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression","volume":"19","author":"Fukuda","year":"2011","journal-title":"Cancer Cell"},{"key":"2026050606013050600_bib22","doi-asserted-by":"crossref","first-page":"5020","DOI":"10.1158\/0008-5472.CAN-11-0908","article-title":"STAT3 plays a critical role in KRAS-induced pancreatic tumorigenesis","volume":"71","author":"Corcoran","year":"2011","journal-title":"Cancer Res"},{"key":"2026050606013050600_bib23","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1158\/1535-7163.MCT-16-0899","article-title":"IL6 receptor blockade enhances chemotherapy efficacy in pancreatic ductal adenocarcinoma","volume":"16","author":"Long","year":"2017","journal-title":"Mol Cancer Ther"},{"key":"2026050606013050600_bib24","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41586-019-1004-y","article-title":"Hepatocytes direct the formation of a pro-metastatic niche in the liver","volume":"567","author":"Lee","year":"2019","journal-title":"Nature"},{"key":"2026050606013050600_bib25","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1158\/2159-8290.CD-19-1353","article-title":"Fibroblast heterogeneity in the pancreatic tumor microenvironment","volume":"10","author":"Helms","year":"2020","journal-title":"Cancer Discov"},{"key":"2026050606013050600_bib26","doi-asserted-by":"crossref","first-page":"104659","DOI":"10.1016\/j.isci.2022.104659","article-title":"Establishment of a reference single-cell RNA sequencing dataset for human pancreatic adenocarcinoma","volume":"25","author":"Chijimatsu","year":"2022","journal-title":"iScience"},{"key":"2026050606013050600_bib27","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","article-title":"Dictionary learning for integrative, multimodal and scalable single-cell analysis","volume":"42","author":"Hao","year":"2024","journal-title":"Nat Biotechnol"},{"key":"2026050606013050600_bib28","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1021\/acs.jproteome.7b00913","article-title":"Extending the compatibility of the SP3 paramagnetic bead processing approach for proteomics","volume":"17","author":"Moggridge","year":"2018","journal-title":"J Proteome Res"},{"key":"2026050606013050600_bib29","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.cell.2010.12.001","article-title":"A tissue-specific atlas of mouse protein phosphorylation and expression","volume":"143","author":"Huttlin","year":"2010","journal-title":"Cell"},{"key":"2026050606013050600_bib30","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/1044-0305(94)80016-2","article-title":"An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database","volume":"5","author":"Eng","year":"1994","journal-title":"J Am Soc Mass Spectrom"},{"key":"2026050606013050600_bib31","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nmeth1019","article-title":"Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry","volume":"4","author":"Elias","year":"2007","journal-title":"Nat Methods"},{"key":"2026050606013050600_bib32","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.cmet.2025.01.024","article-title":"Ergothioneine controls mitochondrial function and exercise performance via direct activation of MPST","volume":"37","author":"Sprenger","year":"2025","journal-title":"Cell Metab"},{"key":"2026050606013050600_bib33","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/s41586-022-05575-3","article-title":"An atlas of substrate specificities for the human serine\/threonine kinome","volume":"613","author":"Johnson","year":"2023","journal-title":"Nature"},{"key":"2026050606013050600_bib34","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/s41586-024-07407-y","article-title":"The intrinsic substrate specificity of the human tyrosine kinome","volume":"629","author":"Yaron-Barir","year":"2024","journal-title":"Nature"},{"key":"2026050606013050600_bib35","doi-asserted-by":"crossref","first-page":"W168","DOI":"10.1093\/nar\/gkad393","article-title":"Enrichr-KG: bridging enrichment analysis across multiple libraries","volume":"51","author":"Evangelista","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"2026050606013050600_bib36","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1126\/science.6150550","article-title":"Platelet-activating factor-induced aggregation of human platelets specifically inhibited by triazolobenzodiazepines","volume":"226","author":"Kornecki","year":"1984","journal-title":"Science"},{"key":"2026050606013050600_bib37","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0006-291X(87)80518-1","article-title":"Triazolobenzodiazepines competitively inhibit the binding of platelet activating factor (PAF) to human platelets","volume":"144","author":"Chesney","year":"1987","journal-title":"Biochem Biophys Res Commun"},{"key":"2026050606013050600_bib38","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.bbr.2014.06.032","article-title":"Role of GABA-active neurosteroids in the efficacy of metyrapone against cocaine addiction","volume":"271","author":"Schmoutz","year":"2014","journal-title":"Behav Brain Res"},{"key":"2026050606013050600_bib39","doi-asserted-by":"crossref","first-page":"D1465","DOI":"10.1093\/nar\/gkad751","article-title":"TTD: therapeutic target database describing target druggability information","volume":"52","author":"Zhou","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"2026050606013050600_bib40","doi-asserted-by":"crossref","first-page":"43654","DOI":"10.1074\/jbc.M407154200","article-title":"Analysis of the presence and abundance of GABAA receptors containing two different types of alpha subunits in murine brain using point-mutated alpha subunits","volume":"279","author":"Benke","year":"2004","journal-title":"J Biol Chem"},{"key":"2026050606013050600_bib41","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neuropharm.2008.07.045","article-title":"GABA A receptors: subtypes provide diversity of function and pharmacology","volume":"56","author":"Olsen","year":"2009","journal-title":"Neuropharmacology"},{"key":"2026050606013050600_bib42","doi-asserted-by":"crossref","first-page":"878","DOI":"10.3389\/fphar.2018.00878","article-title":"The role of toll-like receptor in inflammation and tumor immunity","volume":"9","author":"Cen","year":"2018","journal-title":"Front Pharmacol"},{"key":"2026050606013050600_bib43","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2567.2004.01898.x","article-title":"Toll-like receptor (TLR) expression and TLR-mediated cytokine\/chemokine production by human uterine epithelial cells","volume":"112","author":"Schaefer","year":"2004","journal-title":"Immunology"},{"key":"2026050606013050600_bib44","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3389\/fimmu.2014.00461","article-title":"Toll-like receptor signaling pathways","volume":"5","author":"Kawasaki","year":"2014","journal-title":"Front Immunol"},{"key":"2026050606013050600_bib45","doi-asserted-by":"crossref","first-page":"114747","DOI":"10.1016\/j.bcp.2021.114747","article-title":"Polo-like kinase 1 (PLK1) signaling in cancer and beyond","volume":"193","author":"Iliaki","year":"2021","journal-title":"Biochem Pharmacol"},{"key":"2026050606013050600_bib46","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.cellsig.2012.01.020","article-title":"Autophagy in regulation of Toll-like receptor signaling","volume":"24","author":"Into","year":"2012","journal-title":"Cell Signal"},{"key":"2026050606013050600_bib47","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/ni.3097","article-title":"The kinase MST4 limits inflammatory responses through direct phosphorylation of the adaptor TRAF6","volume":"16","author":"Jiao","year":"2015","journal-title":"Nat Immunol"},{"key":"2026050606013050600_bib48","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1038\/s41423-023-01089-8","article-title":"MST4 kinase regulates immune thrombocytopenia by phosphorylating STAT1-mediated M1 polarization of macrophages","volume":"20","author":"Cao","year":"2023","journal-title":"Cell Mol Immunol"},{"key":"2026050606013050600_bib49","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.3390\/cancers14133293","article-title":"The desmoplastic stroma of pancreatic cancer: multilayered levels of heterogeneity, clinical significance, and therapeutic opportunities","volume":"14","author":"Masugi","year":"2022","journal-title":"Cancers (Basel)"},{"key":"2026050606013050600_bib50","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/s41419-022-05351-1","article-title":"Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma","volume":"13","author":"Zhang","year":"2022","journal-title":"Cell Death Dis"},{"key":"2026050606013050600_bib51","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.apsb.2022.08.014","article-title":"PAFR\/Stat3 axis maintains the symbiotic ecosystem between tumor and stroma to facilitate tumor malignancy","volume":"13","author":"Zhao","year":"2023","journal-title":"Acta Pharm Sin B"},{"key":"2026050606013050600_bib52","doi-asserted-by":"crossref","first-page":"e2406748121","DOI":"10.1073\/pnas.2406748121","article-title":"Platelet-activating factor (PAF) promotes immunosuppressive neutrophil differentiation within tumors","volume":"121","author":"Dahal","year":"2024","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026050606013050600_bib53","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/s41598-017-00515-y","article-title":"Clinically applicable GABA receptor positive allosteric modulators promote \u00df-cell replication","volume":"7","author":"Tian","year":"2017","journal-title":"Sci Rep"},{"key":"2026050606013050600_bib54","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.bja.2021.12.042","article-title":"Midazolam exhibits antitumour and anti-inflammatory effects in a mouse model of pancreatic ductal adenocarcinoma","volume":"128","author":"Oshima","year":"2022","journal-title":"Br J Anaesth"},{"key":"2026050606013050600_bib55","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.brainresbull.2016.02.001","article-title":"TSPO ligand PK11195 alleviates neuroinflammation and beta-amyloid generation induced by systemic LPS administration","volume":"121","author":"Ma","year":"2016","journal-title":"Brain Res Bull"},{"key":"2026050606013050600_bib56","doi-asserted-by":"crossref","first-page":"544431","DOI":"10.3389\/fncel.2020.544431","article-title":"TSPO ligands PK11195 and midazolam reduce NLRP3 inflammasome activation and proinflammatory cytokine release in BV-2 cells","volume":"14","author":"Feng","year":"2020","journal-title":"Front Cell Neurosci"},{"key":"2026050606013050600_bib57","doi-asserted-by":"crossref","first-page":"1244345","DOI":"10.3389\/fimmu.2023.1244345","article-title":"Toll-like receptor-guided therapeutic intervention of human cancers: molecular and immunological perspectives","volume":"14","author":"Mukherjee","year":"2023","journal-title":"Front Immunol"},{"key":"2026050606013050600_bib58","doi-asserted-by":"crossref","first-page":"609579","DOI":"10.1155\/2011\/609579","article-title":"Toll-like receptor 4 activation in cancer progression and therapy","volume":"2011","author":"Oblak","year":"2011","journal-title":"Clin Dev Immunol"},{"key":"2026050606013050600_bib59","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1095\/biolreprod.113.116012","article-title":"Platelet-activating factor: a role in preterm delivery and an essential interaction with Toll-like receptor signaling in mice","volume":"91","author":"Agrawal","year":"2014","journal-title":"Biol Reprod"},{"key":"2026050606013050600_bib60","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1742-2094-11-3","article-title":"Translocator protein (18 kDa; TSPO) is expressed in reactive retinal microglia and modulates microglial inflammation and phagocytosis","volume":"11","author":"Karlstetter","year":"2014","journal-title":"J Neuroinflammation"},{"key":"2026050606013050600_bib61","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.intimp.2018.11.050","article-title":"Midazolam suppresses the lipopolysaccharide-stimulated immune responses of human macrophages via translocator protein signaling","volume":"66","author":"Horiguchi","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"2026050606013050600_bib62","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jare.2024.10.004","article-title":"Effect of mitochondrial translocator protein TSPO on LPS-induced cardiac dysfunction","volume":"74","author":"Li","year":"2025","journal-title":"J Adv Res"},{"key":"2026050606013050600_bib63","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/bs.mcb.2019.11.014","article-title":"Engineering clinically-relevant human fibroblastic cell-derived extracellular matrices","volume":"156","author":"Franco-Barraza","year":"2020","journal-title":"Methods Cell Biol"},{"key":"2026050606013050600_bib64","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1152\/physrev.00048.2019","article-title":"Diversity and biology of cancer-associated fibroblasts","volume":"101","author":"Biffi","year":"2021","journal-title":"Physiol Rev"},{"key":"2026050606013050600_bib65","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1084\/jem.20162024","article-title":"Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer","volume":"214","author":"\u00d6hlund","year":"2017","journal-title":"J Exp Med"},{"key":"2026050606013050600_bib66","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1158\/2159-8290.CD-19-0094","article-title":"Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts","volume":"9","author":"Elyada","year":"2019","journal-title":"Cancer Discov"},{"key":"2026050606013050600_bib67","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1158\/0008-5472.CAN-24-3037","article-title":"Plasticity and functional heterogeneity of cancer-associated fibroblasts","volume":"85","author":"Flynn","year":"2025","journal-title":"Cancer Res"},{"key":"2026050606013050600_bib68","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1158\/1078-0432.CCR-13-0525","article-title":"Inflammatory monocyte mobilization decreases patient survival in pancreatic cancer: a role for targeting the CCL2\/CCR2 axis","volume":"19","author":"Sanford","year":"2013","journal-title":"Clin Cancer Res"},{"key":"2026050606013050600_bib69","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1158\/1078-0432.CCR-16-0870","article-title":"Tumor-derived CCL2 mediates resistance to radiotherapy in pancreatic ductal adenocarcinoma","volume":"23","author":"Kalbasi","year":"2017","journal-title":"Clin Cancer Res"},{"key":"2026050606013050600_bib70","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S1470-2045(16)00078-4","article-title":"Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial","volume":"17","author":"Nywening","year":"2016","journal-title":"Lancet Oncol"},{"key":"2026050606013050600_bib71","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.1158\/1078-0432.CCR-24-1821","article-title":"Neoadjuvant BMS-813160, nivolumab, gemcitabine, and nab-paclitaxel for patients with pancreatic cancer","volume":"31","author":"Grierson","year":"2025","journal-title":"Clin Cancer Res"},{"key":"2026050606013050600_bib72","doi-asserted-by":"crossref","first-page":"e57243","DOI":"10.7554\/eLife.57243","article-title":"Cancer-associated fibroblasts and their influence on tumor immunity and immunotherapy","volume":"9","author":"Barrett","year":"2020","journal-title":"Elife"},{"key":"2026050606013050600_bib73","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1038\/sj.bjc.6605968","article-title":"CXCL12-CXCR4 signalling axis confers gemcitabine resistance to pancreatic cancer cells: a novel target for therapy","volume":"103","author":"Singh","year":"2010","journal-title":"Br J Cancer"},{"key":"2026050606013050600_bib74","doi-asserted-by":"crossref","first-page":"20212","DOI":"10.1073\/pnas.1320318110","article-title":"Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer","volume":"110","author":"Feig","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026050606013050600_bib75","doi-asserted-by":"crossref","first-page":"3934","DOI":"10.1158\/1078-0432.CCR-19-0081","article-title":"Mobilization of CD8+ T cells via CXCR4 blockade facilitates PD-1 checkpoint therapy in human pancreatic cancer","volume":"25","author":"Seo","year":"2019","journal-title":"Clin Cancer Res"},{"key":"2026050606013050600_bib76","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1136\/gutjnl-2016-311585","article-title":"IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer","volume":"67","author":"Mace","year":"2018","journal-title":"Gut"},{"key":"2026050606013050600_bib77","doi-asserted-by":"crossref","first-page":"215722","DOI":"10.1016\/j.canlet.2022.215722","article-title":"Anti-IL-8 antibody activates myeloid cells and potentiates the anti-tumor activity of anti-PD-1 antibody in the humanized pancreatic cancer murine model","volume":"539","author":"Li","year":"2022","journal-title":"Cancer Lett"},{"key":"2026050606013050600_bib78","doi-asserted-by":"crossref","first-page":"D543","DOI":"10.1093\/nar\/gkae1011","article-title":"The PRIDE database at 20 years: 2025 update","volume":"53","author":"Perez-Riverol","year":"2025","journal-title":"Nucleic Acids Res"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-25-0472\/3774942\/crc-25-0472.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/6\/5\/1048\/3790894\/crc-25-0472.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/6\/5\/1048\/3790894\/crc-25-0472.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T10:01:50Z","timestamp":1778061710000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/6\/5\/1048\/784916\/Alprazolam-Reduces-Inflammatory-Cytokine"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":78,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-25-0472","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2767-9764.32703861","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32703870","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32703891","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32703876","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32703897","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32703885","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32703873","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32703903","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32703879","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32703867","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32703900","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2767-9764.c.8542059","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,1]]}}}